Founded in 2018, biotech company Theolytics works to harness viruses to fight cancer. Co-founder and Chief Scientific Officer Margaret Duffy leads the scientific teams and is committed to channelling innovative biological approaches into patient care. She trained as a translational virologist, had a fellowship at Oxford University’s Department of Oncology, and spent several years as a postdoctoral researcher developing viral vector-based therapies. Margaret strives to empower, motivate and collaborate her team to achieve great things.
